Vitamin D and infection

Vitamin D: Oxidative Stress, Immunity, and Aging

Volumn , Issue , 2012, Pages 323-350

  Bartley, Jim ^a   Camargo, Carlos A ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891403951     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13714     Document Type: Chapter

References (233)

1. Ralph, A., P. Kelly, and N. Anstey. 2008. l-arginine and vitamin D: Novel adjunctive immunotherapies in tuberculosis. Trends in Microbiology 16:336-344.
2. Hobday, R. 1997. Sunlight therapy and solar architecture. Medical History 41:455-472.
3. Holick, M. 2007. Vitamin D deficiency. New England Journal of Medicine 357:266-281.
4. Bicknell, A. B. 2008. The tissue-specific processing of pro-opiomelanocortin. Journal of Neuroendocrinology 20:692-699.
5. Brzoska, T., T. A. Luger, C. Maaser, C. Abels, and M. Bohm. 2008. Alpha-melanocyte-stimulating hormone and related tripeptides: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews 29:581-602.
6. Selmi, C., and K. Tsuneyama. 2010. Nutrition, geoepidemiology, and autoimmunity. Autoimmunity Reviews 9:A267-A270.
7. 3 is a direct inducer of antimicrobial peptide gene expression. The Journal of Immunology 173:2909-2912.
8. Liu, P. T., S. Stenger, H. Li et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
9. Adams, J. S., and M. Hewison. 2008. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nature Clinical Practice. Endocrinology & Metabolism 4:80-90.
10. Liu, P., S. Stenger, D. Tang, and R. Modlin. 2007. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. The Journal of Immunology 179:2060-2063.
11. Bruce, D., J. Ooi, S. Yu, and M. Cantorna. 2010. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Experimental Biology and Medicine 235:921-927.
12. Grey, A., and M. Bolland. 2010. Vitamin D a place in the sun? Archives of Internal Medicine 170:1099-1020.
13. Gudmundsson, G., and B. Agerberth. 1999. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. The Journal of Immunology Methods 232:45-54.
14. Ganz, T. 2004. Antimicrobial polypeptides. Journal of Leukocyte Biology 75:34-38.
15. Brogden, K. 2005. Antimicrobial peptides: Pore inhibitors or metabolic inhibitors in bacteria? Nature Reviews. Microbiology 3:238-350.
16. Costerton, J. W. 1999. Bacterial biofilms: A common cause of persistent infections. Science 284:1318-1322.
17. Dunne, W. M. 2002. Bacterial adhesion: Seen any good biofilms lately? Clinical Microbiology Reviews; 15:155-166.
18. Otto, M. 2006. Bacterial evasion of antimicrobial peptides by biofilm formation. Current Topics in Microbiology and Immunology 306:251-258.
19. Taggart, C., C. Greene, S. Smith et al. 2003. Inactivation of human [beta]-defensins 2 and 3 by elastolytic cathepsins. The Journal of Immunology 171:931-937.
20. Schmidtchen, A., I. Frick, E. Andersson, H. Tapper, and L. Björck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Molecular Microbiology 46:157-168.
21. Rosenfeld, Y., and Y. Shai. 2006. Lipopolysaccharide (endotoxin)-host defense antibacterial peptides interactions: Role in bacterial resistance and prevention of sepsis. Biochimica et Biophysica Acta 1758:1513-1522.
22. Overhage, J., A. Campisano, M. Bains, E. C. W. Torfs, B. H. A. Rehm, and R. E. W. Hancock. 2008. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infection and Immunity 76:4176-4182.
23. Chennupati, S. K., A. G. Chiu, E. Tamashiro et al. 2009. Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. American Journal of Rhinology & Allergy 23:46-51.
24. Mahon, B. D., A. Wittke, V. Weaver, and M. T. Cantorna. 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry 89:922-932.
25. von Essen, M. R., M. Kongsbak, P. Schjerling, K. Olgaard, N. Ødum, and C. Geisler. 2010. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nature Immunology 11:344-349.
26. Uitterlinden, A., Y. Fang, J. Van Meurs, H. Pols, and J. Van Leeuwen. 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143-156.
27. Selvaraj, P., G. Chandra, M, Jawahar, M. Rani, D. Rajeshwari, and P. Narayanan. 2004. Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. Journal of Clinical Immunology 24:423-432.
28. Roth, D., G. Soto, F. Arenas et al. 2004. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. The Journal of Infectious Diseases 190:920-927.
29. Arai, H., K. Miyamoto, Y. Taketani et al. 1997. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. Journal of Bone and Mineral Research 12:915-921.
30. McGrath, J. J., S. Saha, T. H. J. Burne, and D. W. Eyles. 2010. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. The Journal of Steroid Biochemistry and Molecular Biology 121:471-477.
31. Finsen, N. 1903. Remarks on the red-light treatment of small-pox. Is the treatment of small-pox patients in broad daylight warrantable? British Medical Journal 1(2214).
32. Møller, K., B. Kongshoj, P. Philipsen, V. Thomsen, and H. Wulf. 2005. How Finsen’s light cured lupus vulgaris. Photodermatology, Photoimmunology & Photomedicine 21:118-124.
33. Ritter, M. A., E. M. Olberding, and R. A. Malinzak. 2007. Ultraviolet lighting during orthopaedic surgery and the rate of infection. Journal of Bone and Joint Surgery. American Volume 89:1935-1940.
34. Krutmann, J. 2009. Pre- and probiotics for human skin. Journal of Dermatological Science 54:1-5.
35. Bikle, D. D. 2004. Vitamin D regulated keratinocyte differentiation. Journal of Cellular Biochemistry 92:436-444.
36. Oda, Y., Y. Uchida, S. Moradian, D. Crumrine, P. M. Elias, and D. D. Bikle. 2008. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. The Journal of Investigative Dermatology 129:1367-1378.
37. Hong, S. P., M. J. Kim, M.-Y. Jung et al. 2008. Biopositive effects of low-dose UVB on epidermis: Coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. The Journal of Investigative Dermatology 128:2880-2887.
38. Frohm, M., B. Agerberth, G. Ahangari et al. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. Journal of Biological Chemistry 272:15258-15263.
39. Ong, P., T. Ohtake, C. Brandt et al. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. New England Journal of Medicine 347:1151-1160.
40. Howell, M., A. Wollenberg, R. Gallo et al. 2006. Cathelicidin deficiency predisposes to eczema herpeticum. The Journal of Allergy and Clinical Immunology 117:836-841.
41. Weiland, S. K. 2004. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occupational and Environmental Medicine 61:609-615.
42. Byremo, G., G. Rød, and K. H. Carlsen. 2006. Effect of climatic change in children with atopic eczema. Allergy 61:1403-1410.
43. Peroni, D. G., G. L. Piacentini, E. Cametti, I. Chinellato, and A. L. Boner. 2011. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. The British Journal of Dermatology 164:1078-1082.
44. Mallbris, L., L. Carlén, T. Wei et al. 2010. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Experimental Dermatology 19:442-449.
45. Hata, T., P. Kotol, M. Jackson et al. 2008. Administration of oral vitamin D induces cathelicidin production in atopic individuals. The Journal of Allergy and Clinical Immunology 122:829-831.
46. Sidbury, R., A. F. Sullivan, R. I. Thadhani, and C. A. Camargo, Jr. 2008. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: A pilot study. The British Journal of Dermatology 159:245-247.
47. Khandsuren, B., D. Ganmaa, R. Sidbury, K. Erdenedelger, N. Radnaakhand, and C. A. Camargo, Jr. 2009. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Mongolian children [abstract] Presented at the World Congress of Pediatric Dermatology (Bangkok, Thailand; November 17-19, 2009).
48. Krämer, C., H. Seltmann, M. Seifert, W. Tilgen, C. C. Zouboulis, and J. Reichrath. 2009. Characterization of the vitamin D endocrine system in human sebocytes in vitro. The Journal of Steroid Biochemistry and Molecular Biology 113:9-16.
49. Kalayciyan, A., O. Oguz, H. Bahar, M. Torun, and E. Aydemir. 2002. In vitro bactericidal effect of low-dose ultraviolet B in patients with acne. Journal of the European Academy of Dermatology and Venereology 16:642-643.
50. Shnitkind, E., E. Yaping, S. Geen, A. Shalita, and W. Lee. 2006. Anti-inflammatory properties of narrow-band blue light. Journal of Drugs in Dermatology 5:605-610.
51. Sigmon, J. R., B. A. Yentzer, S. R. Feldman. 2009. Calcitriol ointment: A review of a topical vitamin D analog for psoriasis. The Journal of Dermatological Treatment 20:208-212.
52. Peric, M., S. Koglin, Y. Dombrowski et al. 2009. Vitamin D analogs differentially control antimicrobial peptide/“alarmin” expression in psoriasis. PLoS One 4:e6340.
53. Ghoreishi, M., P. Bach, J. Obst, M. Komba, J. C. Fleet, J. P. Dutz. 2009. Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. The Journal of Immunology 182:6071-6078.
54. Loser, K., and S. Beissert. 2009. Regulation of cutaneous immunity by the environment: An important role for UV irradiation and vitamin D. International Immunopharmacology 9:587-589.
55. Fitness, J., K. Tosh, and A. Hill. 2002. Genetics of susceptibility to leprosy. Genes and Immunity 3:441-453.
56. Roy, S., A. Frodsham, B. Saha, S. Hazra, C. Mascie-Taylor, and A. Hill. 1999. Association of vitamin D receptor genotype with leprosy type. The Journal of Infectious Diseases 179:187-191.
57. Fitness, J., S. Floyd, D. Warndorff et al. 2004. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. The American Journal of Tropical Medicine and Hygiene 71:330-340.
58. Matzner, M., A. R. Al Samie, H-M. Winkler et al. 2011. Low serum levels of cathelicidin LL-37 in leprosy. Acta Tropica 117:56-59.
59. Takahashi, N., and B. Nyvad. 2011. The role of bacteria in the caries process: ecological perspectives. Journal of Dental Research 90:294-303.
60. East, B. 1939. Mean annual hours of sunshine and incidence of dental caries. American Journal of Public Health 29:777-780.
61. East, B., and H. Kaiser. 1940. Relation of dental caries in rural children to sex, age and environment. American Journal of Diseases of Children 60:1289-1303.
62. McBeath, E., and T. Zucker. 1938. The role of vitamin D in the control of dental caries. American Journal of Public Health 15:547-564.
63. Hargreaves, J. A., and G. W. Thompson. 1989. Ultraviolet light and dental caries in children. Caries Research 23:389-392.
64. Putsep, K., G. Carlsson, H. Boman, and M. Andersson. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149.
65. Dietrich, T., M. Nunn, B. Dawson-Hughes, and H. Bischoff-Ferrari. 2005. Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. The American Journal of Clinical Nutrition 82:575-580.
66. Tachi, Y. 2003. Vitamin D receptor gene polymorphism is associated with chronic periodontitis. Life Sciences 73:3313-3321.
67. De Brito, R., R. Scarel-Caminiaga, P. Trevilatto, A. de Souza, and S. Barros. 2004. Polymorphisms in the vitamin D receptor gene are associated with periodontal disease. Journal of Periodontology 75:1090-1095.
68. Krall, E. 2006. Osteoporosis and the risk of tooth loss. Clinical Calcium 16:287-290.
69. 3 and periodontal disease in the US population. The American Journal of Clinical Nutrition 80:108-113.
70. Boggess, K. A., J. A. Espinola, K. Moss, J. Beck, S. Offenbacher, C. A. Camargo, Jr. 2011. Vitamin D status and periodontal disease among pregnant women. Journal of Periodontology 82:195-200.
71. Krall, E., C. Wehler, R. Garcia, S. Harris, B. Dawson-Hughes. 2001. Calcium and vitamin D supplements reduce tooth loss in the elderly. American Journal of Medicine 111:452-456.
72. Garcia, M. N., C. F. Hildebolt, D. D. Miley et al. 2011. One-year effects of vitamin D and calcium supplementation on chronic periodontitis. Journal of Periodontology 82:25-32.
73. Sawatari, Y., and R. Marx. 2007. Bisphosphonates and bisphosphonate induced osteonecrosis. Oral and Maxillofacial Surgery Clinics of North America 19:487-498.
74. Vescovi, P., and S. Nammour. 2010. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) therapy. A critical review. Minerva Stomatologica 59:181-213.
75. Hokugo, A., R. Christensen, E. M. Chung et al. 2010. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. Journal of Bone and Mineral Research 25:1337-1349.
76. Martineau, A., F. Honecker, R. Wilkinson, and C. Griffiths. 2007. Vitamin D in the treatment of pulmonary tuberculosis. The Journal of Steroid Biochemistry and Molecular Biology 103:793-798.
77. Gaumond, E. 1948. Lupus vulgaris and vitamin D. Canadian Medical Association Journal 59:522-526.
78. Bellamy, R., C. Ruwende, T. Corrah et al. 1999. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. The Journal of Infectious Diseases 179:721-724.
79. Wilkinson, R. J., M. Llewelyn, Z. Toosi et al. 2000. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study. Lancet 355:618-621.
80. Rook, G. 1988. The role of vitamin D in tuberculosis. The American Review of Respiratory Disease 138:768-770.
81. Nnoaham, K. E., and A. Clarke. 2007. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. International Journal of Epidemiology 37:113-119.
82. Talat, N., S. Perry, J. Parsonnet, G. Dawood, and R. Hussain. 2010. Vitamin D deficiency and tuberculosis progression. Emerging Infectious Diseases 16:853-855.
83. Vieth, R. 2011. Vitamin D nutrient to treat TB begs the prevention question. Lancet 377:189-190.
84. 2. The American Journal of Clinical Nutrition 68:854-858.
85. 3 in humans. The Journal of Clinical Endocrinology and Metabolism 89:5387-5391.
86. Nursyam, E., Z. Amin, and C. Rumende. 2006. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Medica Indonesiana 38:3-5.
87. Wejse, C., V. F. Gomes, P. Rabna et al. 2009. Vitamin D as supplementary treatment for tuberculosis: A double-blind, randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine 179:843-850.
88. 3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 377:242-250.
89. Panierakis, C., G. Goulielmos, D. Mamoulakis, S. Maraki, E. Papavasiliou, and E. Galanakis. 2009. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes. International Journal of Infectious Diseases 13:e437-e443.
90. Matheson, E. M., A. G. Mainous, W. J. Hueston, V. A. Diaz, and C. J. Everett. 2010. Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scandinavian Journal of Infectious Diseases 42:455-460.
91. Laaksi, I., J. Ruohola, P. Tuohimaa et al. 2007. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. The American Journal of Clinical Nutrition 86:714-717.
92. Temorschuizen, F., A. Wijga, J. Gerritsen, H. Neijens, and H. van Loveren. 2004. Exposure to solar ultraviolet radiation and respiratory tract symptoms in 1-year-old children. Photodermatology, Photoimmunology & Photomedicine 20:270-271.
93. Cannell, J. J., M. Zasloff, C. F. Garland, R. Scragg, and E. Giovannucci. 2008. On the epidemiology of influenza. Virology Journal 5:29.
94. Linday, L., R. Shindledecker, J. Dolitsky, T. Chen, and M. Holick. 2008. Plasma 25-hydroxyvitamin D levels in young children undergoing placement of tympanostomy tubes. The Annals of Otology, Rhinology, and Laryngology 117:740-744.
95. Reid, D., R. Morton, L. Salkeld, and J. Bartley. 2011. Vitamin D and tonsil disease-preliminary observations. International Journal of Pediatric Otorhinolaryngology 75:261-264.
96. Elemraid, M. A., I. J. Mackenzie, W. D. Fraser et al. 2011. A case-control study of nutritional factors associated with chronic suppurative otitis media in Yemeni children. European Journal of Clinical Nutrition.
97. Pinto, J., J. Schneider, R. Perez, M. DeTineo, F. Baroody, R. Naclerio. 2008. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. The Journal of Allergy and Clinical Immunology 122:415-417.
98. Ginde, A., J. Mansbach, and C. A. Camargo, Jr. 2009. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third National Health and Nutrition Examination Survey. Archives of Internal Medicine 169:384-390.
99. Sabetta, J. R., P. DePetrillo, R. J. Cipriani, J. Smardin, L. A., Burns, and M. L. Landry. 2010. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract Infections in healthy adults. PLoS One 5:e11088.
100. Berry, D. J., K. Hesketh, C. Power, and E. Hyppönen. 2011. Vitamin D status has a linear association with seasonal infections and lung function in British adults. The British Journal of Nutrition 106:1433-1440.
101. Chesney, R. 2010. Vitamin D and the magic mountain: The anti-infectious role of the vitamin. Journal of Pediatrics 156:698-703.
102. Mariam, T., and G. Sterky. 1973. Severe rickets in infancy and childhood in Ethiopia. Journal of Pediatrics 82:876-878.
103. El-Radhi, A., M. Majeed, N. Mansor, and M. Ibrahim. 1982. High incidence of rickets in children with wheezy bronchitis in a developing country. Journal of the Royal Society of Medicine 75:884-887.
104. Muhe, L., S. Lulseged, K. Mason, and E. Simoes. 1997. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 349:1801-1804.
105. Banajeh, S., N. al-Sunbali, and S. al-Sanahan. 1997. Clinical characteristics and outcome of children aged under 5 years hospitalized with severe pneumonia in Yemen. Annals of Tropical Paediatrics 17:321-326.
106. Najada, A, M. Habashneh, and M. Khader. 2004. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. Journal of Tropical Pediatrics 50:364-368.
107. Banajeh, S. M. 2009. Nutritional rickets and vitamin D deficiency association with the outcomes of childhood very severe pneumonia: A prospective cohort study. Pediatric Pulmonology 44:1207-1215.
108. Belderbos, M. E., M. L. Houben, B. Wilbrink et al. 2011. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 127:e1513-e1520.
109. Karatekin, G., A. Kaya, Ö. Salihoğlu, H. Balci, and A. Nuhoğlu. 2007. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. European Journal of Clinical Nutrition 63:473-477.
110. McNally, J. D., K. Leis, L. A. Matheson, C. Karuananyake, K. Sankaran, and A. M. Rosenberg. 2009. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatric Pulmonology 44:981-988.
111. Wayse, V., A. Yousafzai, K. Mogale, and S. Filteau. 2004. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. European Journal of Clinical Nutrition 58:563-567.
112. Inamo, Y., M. Hasegawa, K. Saito et al. 2011. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatrics International 53:199-201.
113. Roth, D. E., A. B. Jones, C. Prosser, J. L. Robinson, and S. Vohra. 2007. Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. European Journal of Clinical Nutrition 63:297-299.
114. Roth, D. E., A. B. Jones, C. Prosser, J. L. Robinson, and S. Vohra. 2008. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. The Journal of Infectious Diseases 197:676-680.
115. Grant, W., and E. Giovannucci. 2009. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinology 1:215-219.
116. Douglas, A., D. Strachan, and J. Maxwell. 1996. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax 51:944-946.
117. Leow, L., T. Simpson, R. A. Y. Cursons, N. Karalus, and R. J. Hancox. 2011. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 16:611-616.
118. Green, D., K. Carson, A. Leonard et al. 2008. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. Journal of Pediatrics 153:554-559.
119. Pincikova, T., K. Nilsson, I. E. Moen et al. 2010. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. European Journal of Clinical Nutrition 65:102-109.
120. Janssens, W., R. Bouillon, B. Claes et al. 2009. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65:215-220.
121. Chishimba, L., D. R. Thickett, R. A. Stockley, and A. M. Wood. 2010. The vitamin D axis in the lung: A key role for vitamin D-binding protein. Thorax 65:456-462.
122. Holmes, A., M. Pigott, W. Sawyer, and L. Comstock. 1932. Vitamins aid reduction of lost time in industry. Industrial and Engineering Chemistry 24:1058-1060.
123. Holmes, A., M. Pigott, W. Sawyer, and L. Comstock. 1936. Cod liver oil-a five year study of its value for reducing industrial absenteeism caused by colds and respiratory diseases. Industrial Medicine 5:359-361.
124. Gigineishvili, G., N. Il’in, R. Suzdalʼnitskiii, and V. Levando. 1990. The use of irradiation to correct the immune system and decrease morbidity in athletes [in Russian] Vopr Kurotol Fizioter Lech Fiz Kult May-Jun, 30-3 cited in.
125. Cannell, J. J., R. Vieth, W. Willett, M. Zasloff, J. N. Hathcock, J. H. White et al. 2008. Cod liver oil, vitamin A toxicity, frequent respiratory tract infections and the vitamin D epidemic. The Annals of Otology, Rhinology, and Laryngology 117:864-870.
126. Rehman, P. 1994. Sub-clinical rickets and recurrent infection. Journal of Tropical Pediatrics 40:58.
127. Aloia, J. F., M. Li-Ng. 2007. Re: Epidemic influenza and vitamin D. Epidemiology and Infection 135:1095-1096.
128. Avenell, A., J. Cook, G. MacLennan, and G. MacPherson. 2007. Vitamin D supplementation to prevent infections: A substudy of a randomised placebo-controlled trial in older people. Age and Ageing 36:574-577.
129. Tsujimoto, Y., H. Tahara, T. Shoji et al. 2011. Active vitamin D and acute respiratory infections in dialysis patients. Clinical Journal of the American Society of Nephrology 6:1361-1367.
130. 3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiology and Infection 137:1396-1404.
131. Urashima, M., T. Segawa, M. Okazaki, M. Kurihara, Y. Wada, and H. Ida. 2010. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. The American Journal of Clinical Nutrition 91:1255-1260.
132. Laaksi, I., J. P. Ruohola, V. Mattila, A. Auvinen, T. Ylikomi, and H. Pihlajamäki. 2010. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. Journal of Infectious Diseases 202:809-814.
133. Manaseki-Holland, S., G. Qader, M. Isaq Masher et al. 2010. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomized controlled trial. Tropical Medicine & International Health 15:1148-1155.
134. 3 supplementation in the elderly. Osteoporosis International 20:1407-1415.
135. Black, P., and R. Scragg. 2005. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third National Health and Nutrition Examination Survey. Chest 128:3792-3798.
136. Masoli, M., D. Fabian, S. Holt, and R. Beasley; Global Initiative for Asthma (GINA) Program. 2004. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 59:469-478.
137. Raby, B., R. Lazarus, E. Silverman et al. 2004. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. American Journal of Respiratory and Critical Care Medicine 170:1057-1065.
138. Saadi, A., G. Gao, H. Li, C. Wei, Y. Gong, and Q. Liu. 2009. Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: A case-control study. BMC Medical Genetics 10:71.
139. Camargo, C. A. Jr., T. Ingham, K. Kristin Wickens et al. 2011. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 127:e180-e187.
140. Brehm, J., B. Schuemann, A. Fuhlbrigge et al. 2010. Serum vitamin D levels and severe asthma exacerbations in the childhood asthma management program study. The Journal of Allergy and Clinical Immunology 126:52-58.
141. Majak, P., M. Olszowiec-Chlebna, K. Smejda, and I. Stelmach. 2011. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. The Journal of Allergy and Clinical Immunology 127:1294-1296. Feb 9. [Epub ahead of print].
142. Carroll, K. N., T. Gebretsadik, E. K. Larkin et al. 2011. Relationship of maternal vitamin D level with maternal and infant respiratory disease. American Journal of Obstetrics and Gynecology.
143. Hyppönen, E., U. Sovio, M. Wjst et al. 2004. Infant vitamin D supplementation and allergic conditions in adulthood: Northern Finland birth cohort 1966. Annals of the New York Academy of Sciences 1037:84-95.
144. Hyppönen, E., D. J. Berry, M. Wjst, and C. Power. 2009. Serum 25-hydroxyvitamin D and IgE-a significant but nonlinear relationship. Allergy 64:613-620.
145. Miyake, C. Y., K. Gauvreau, L. Y. Tani, R. P. Sundel, and J. W. Newburger. 2007. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 120:503-508.
146. Finkelhor, R., G. Cater, A. Qureshi, D. Einstadter, M. Hecker, and G. Bosich. 2005. Seasonal diagnosis of echocardiographically demonstrated endocarditis. Chest 128:2588-2592.
147. D’Aldebert, E., Bi. Biyeyeme, M. J. Mve, M. Mergey et al. 2009. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 136:1435-1443.
148. Arteh, J., S. Narra, and S. Nair. 2009. Prevalence of vitamin D deficiency in chronic liver disease. Digestive Diseases and Sciences 55:2624-2628.
149. Arababadi, M. K., A. A. Pourfathollah, A. Jafarzadeh, G. Hassanshahi, and M. E. Rezvani. 2010. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. Journal of Gastroenterology and Hepatology 25:90-93.
150. Suneetha, P., S. Sarin, A. Goyal, G. Kumar, D. Shukla, and S. Hissar. 2006. Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease. Journal of Hepatology 44:856-863.
151. Petta, S., C. Cammà, C. Scazzone et al. 2010. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 51:1158-1167.
152. Lange, C. M., J. Bojunga, E. Ramos-Lopez et al. 2011. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. Journal of Hepatology 54:887-893.
153. Bitetto, D., G. Fattovich, C. Fabris et al. 2011. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 53:1118-1126.
154. Abu-Mouch, S. 2009. Abstract LB20. The Liver Meeting 2009:60th Annual Meeting of the American Association for the Study of Liver Diseases.
155. McCracken, V., and R. Lorenz. 2001. The gastrointestinal ecosystem: A precarious alliance among epithelium, immunity and microbiota. Cellular Microbiology 3:1-11.
156. Hase, K., M. Murakami, M. Iimura et al. 2003. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125:1613-1625.
157. George, J. 2003. Host anti-microbial response to Helicobacter pylori infection. Molecular Immunology 40:451-456.
158. Nasri, H., and A. Baradaran. 2007. The influence of serum 25-hydroxy vitamin D levels on Helicobacter pylori infections in patients with end-stage renal failure on regular hemodialysis. Saudi Journal of Kidney Diseases and Transplantation 18:215-219.
159. 3 administration on Helicobacter pylori infection. Journal of Clinical Biochemistry and Nutrition 38:103-106.
160. 3 One-α-hydroxy-cholecalciferol-an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Danish Medical Bulletin 55:186-210.
161. Yamshchikov, A., N. Desai, H. Blumberg, T. Ziegler, and V. Tangpricha. 2009. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocrine Practice 15:438-449.
162. Lagishetty, V., A. V. Misharin, N. Q. Liu et al. 2010. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151:2423-2432.
163. Kelly, P., M. Bajaj-Elliott, M. Katubulushi et al. 2006. Reduced gene expression of intestinal [α]-defensins predicts diarrhea in a cohort of African adults The Journal of Infectious Diseases 193:1464-1470.
164. 3 administration in mice. Drug Metabolism and Disposition 37:2037-2044.
165. Chawla, A. 2001. Nuclear receptors and lipid physiology: Opening the X-files. Science 294:1866-1870.
166. Gombart, A. 2009. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiology 4:1151-1165.
167. Islam, D., L. Bandholtz, J. Nilsson et al. 2001. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator. Nature Medicine 7:180-185.
168. Gudmundsson, G. H., P. Bergman, J. Andersson, R. Raqib, and B. Agerberth. 2010. Battle and balance at mucosal surfaces-the story of Shigella and antimicrobial peptides. Biochemical and Biophysical Research Communications 396:116-119.
169. Schwab, M., V. Reynders, Y. Shastri, S. Loitsch, J. Stein, and O. Schroder. 2007. Role of nuclear hormone receptors in butyrate-mediated up-regulation of the antimicrobial peptide cathelicidin in epithelial colorectal cells. Molecular Immunology 44:2107-2114.
170. Frank, D. N., A. L. St. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, N. R. Pace. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America 104:13780-13785.
171. Maslowski, K. M., A. T. Vieira, A. Ng et al. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282-1286.
172. Villamor, E. 2006. A potential role for vitamin D on HIV infection? Nutrition Review 64:226-233.
173. Bergman, P., L. Walter-Jallow, K. Broliden, B. Agerberth, and J. Södelund. 2007. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Current HIV Research 5:410-415.
174. de la Torre Manuel, S., C. Torres, G. Nieto et al. 2008. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. The Journal of Infectious Diseases 197:405-410.
175. Nieto, G., Y. Barber, M. Rubio, M. Rubio, and J. Fibla. 2004. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. The Journal of Steroid Biochemistry and Molecular Biology 89-90:199-207.
176. Bang, U. C., S. A. Shakar, M. F. Hitz et al. 2010. Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study. Scandinavian Journal of Infectious Diseases 42:306-310.
177. Haug, C., F. Muller, P. Aukrust, and S. Froland. 1994. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. The Journal of Infectious Diseases 169:889-893.
178. Viard, J-P., J-C. Souberbielle, O. Kirk et al. 2011. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25:1305-1315.
179. Mehta, S., D. J. Hunter, F. M. Mugusi et al. 2009. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. The Journal of Infectious Diseases 200:1022-1030.
180. Mehta, S. E. Giovannucci, F. M. Mugusi et al. 2010. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 5:e8770.
181. Zasloff, M. 2007. Antimicrobial peptides, innate Immunity, and the normally sterile urinary tract. Journal of the American Society of Nephrology 18:2810-2816.
182. Lehmann, J., M. Retz, J. Harder et al. 2002. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infectious Diseases 2:20.
183. Chromek, M., Z. Slamova, P. Bergman et al. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nature Medicine 12:636-641.
184. Hertting, O., A. Holm, P. Luthje et al. 2010. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One 5:e15580.
185. Morrison, G. 2002. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infection and Immunity 70:3053-3060.
186. Katikaneni, R., T. Ponnapakkam, A. Ponnapakkam, and R. Gensure. 2009. Breastfeeding does not protect against urinary tract infection in the first 3 months of life, but vitamin D supplementation increases the risk by 76%. Clinical Pediatrics 48:750-755.
187. Linday, L. A., R. D. Shindledecker, F. R. Greer, and M. F. Holick. 2009. Commentary on “Breastfeeding does not protect against urinary tract infection in the first 3 months of life, but vitamin D supplementation increases the risk by 76%.” Clinical Pediatrics 49:93-94.
188. Sorensen, O. 2003. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in the vagina. Journal of Biological Chemistry 278:28540-28546.
189. Bodnar, L. M., M. A. Krohn, and H. N. Simhan. 2009. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. Journal of Nutrition 139:1157-1161.
190. Hensel, K., T. Randis, S. Gelber, and A. Ratner. 2011. Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis. American Journal of Obstetrics and Gynecology 204:41e1-e9.
191. Venkataraman, N., A. Cole, P. Svoboda, J. Pohl, and A. Cole. 2005. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. The Journal of Immunology 175:7560-7567.
192. Etzioni, A., Z. Hochberg, and S. Pollak et al. 1989. Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin D. Pediatric Research 25:276-279.
193. Lopez-Garcia, B., P. Lee, K. Yamasaki, and R. Gallo. 2005. Antifungal activity of cathelicidins and their potential role in Candida albicans skin infection. The Journal of Investigative Dermatology 125:108-115.
194. Conner, K., K. Nern, J. Rudisill, T. Ogrady, and R. Gallo. 2002. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. Journal of the American Academy of Dermatology 47:347-350.
195. Meyer-Hoffert, U., T. Schwarz, J. M. Schröder, and R. Gläser. 2008. Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata. Journal of the European Academy of Dermatology and Venereology 22:1050-1054.
196. Kinlin, L. M., C. V. Spain, V. Ng, C. C. Johnson, A. N. J. White, and D. N. Fisman. 2008. Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scales. American Journal of Epidemiology 169:588-595.
197. Hope-Simpson, R. 1965. The nature of herpes zoster: A long-term study and a new hypothesis. Proceedings of the Royal Society of Medicine 58:9-20.
198. Jalali, M. H. A., H. Ansarin, and R. Soltani-Arabshahi. 2006. Broad-band ultraviolet B phototherapy in zoster patients may reduce the incidence and severity of postherpetic neuralgia. Photodermatology, Photoimmunology & Photomedicine 22:232-237.
199. Bartley, J. 2009. Post herpetic neuralgia, Schwann cell activation and vitamin D. Medical Hypotheses 73:927-929.
200. McDermott, A. M. 2009. The role of antimicrobial peptides at the ocular surface. Ophthalmic Research 41:60-75.
201. Wu, M., S. A. McClellan, R. P. Barrett, Y. Zhang, and L. D. Hazlett. 2009. Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. The Journal of Immunology 183:8054-8060.
202. Li, Q., A. Kumar, J.-F. Gui, and F-SX. Yu. 2008. Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2. Microbial Pathogenesis 44:426-434.
203. Stallmann, H., C. Faber, A. Nieuw Amerongen, and P. Wuisman. 2006. Antimicrobial peptides: review of their application in musculoskeletal infections. Injury 37:S34-40.
204. Malik, M. H. A., F. Jury, A. Bayat, W. E. R. Ollier, and P. R. Kay. 2007. Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Annals of the Rheumatic Diseases 66:1116-1120.
205. Bischoff-Ferrari, H. A., B. Dawson-Hughes, A. Platz et al. 2010. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Archives of Internal Medicine 170:813-820.
206. Grant, W. 2009. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinology 1:37-42.
207. Danai, P. A., S. Sinha, M. Moss, M. J. Haber, and G. S. Martin. 2007. Seasonal variation in the epidemiology of sepsis. Critical Care Medicine 35:410-415.
208. Drechsler, C., S. Pilz, B. Obermayer-Pietsch et al. 2010. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. European Heart Journal 31:2253-2261.
209. Gombart, A., I. Bhan, N. Borregaard et al. 2009. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clinical Infectious Diseases 48:418-424.
210. Jeng, L., A. V. Yamshchikov, S. E. Judd et al. 2009. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. Journal of Translational Medicine 7:28.
211. Ginde, A. A., C. A. Camargo, Jr., and N. I. Shapiro. 2011. Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. Academic Emergency Medicine 18:551-554.
212. Daynes, R. A., and B. A. Araneo. 1994. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo. Annals of the New York Academy of Sciences 730:144-161.
213. Daynes, R. A., E. Y. Enioutina, S. Butler, H.-H. Mu, Z. A. McGee, B. A. Araneo. 1996. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infection and Immunity 64:1100-1109.
214. Kriesel, J., and J. Spruance. 1999. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with the influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 17:1883-1888.
215. Chadha, M. K., M. Fakih, J. Muindi et al. 2011. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 71:368-372.
216. Lalor, M., S. Floyd, P. Gorak-Stolinska et al. 2011. BCG vaccination: A role for vitamin D? PLoS One 6:e16709.
217. Narayanan, D., R. Saladi, and J. Fox. 2010. Ultraviolet radiation and skin cancer. International Journal of Dermatology 49:978-986.
218. LoPiccolo, M., and H. Lim. 2010. Vitamin D in health and disease. Photodermatology, Photoimmunology & Photomedicine 26:224-229.
219. Pearce, S. H., and T. D. Cheetham. 2010. Diagnosis and management of vitamin D deficiency. British Medical Journal 340:b5664-b.
220. 3 is as effective as an oral supplement in maintaining vitamin D status in adults. The American Journal of Clinical Nutrition 91:1621-1626.
221. 3 under various input conditions. The American Journal of Clinical Nutrition 87:1738-1742.
222. Heaney, R., K. Davies, T. Chen, M. Holick, and M. Barger-Lux. 2003. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol The American Journal of Clinical Nutrition 77:204-210 [Erratum.
223. Am. J. Clin. Nutr. 78:1047].
224. Institute of Medicine (IOM). 2011. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press.
225. Aloia, J., M. Patel, R. Dimaano et al. 2008. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. The American Journal of Clinical Nutrition 87:1952-1958.
226. Reid, D., B. Toole, S. Knox et al. 2011. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. The American Journal of Clinical Nutrition 93:1006-1011.
227. Hathcock, J. N., A. Shao, R. Vieth, and R. Heaney. 2007. Risk assessment for vitamin D. The American Journal of Clinical Nutrition 85:6-18.
228. Heaney, R. P. 2008. Vitamin D: criteria for safety and efficacy. Nutrition Review 66:S178-S181.
229. Rothers, J., A. Wright, M. Halonen, C. A. Camargo, Jr. 2011. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. The Journal of Allergy and Clinical Immunology 128:1093-1099.
230. Nielsen, N. O., T. Skifte, M. Andersson et al. 2010. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. The British Journal of Nutrition 104:1487-1491.
231. Michaelsson, K., J. A. Baron, G. Snellman et al. 2010. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. The American Journal of Clinical Nutrition 92:841-848.
232. Bischoff-Ferrari, H. A., A. Shao, B. Dawson-Hughes, J. Hathcock, E. Giovannucci, and W. C. Willett. 2010. Benefit-risk assessment of vitamin D supplementation. Osteoporosis International 21:1121-1132.
233. Morcos, M., A. Gabr, S. Samuel et al. 1998. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico 137:157-164.